Bladder Cancer Global Clinical Trials Market Review, H1, 2014 @ http://www.researchmoz.us/bladder-cancer-global-clinical-trials-review-h1-2014-report.html This report provides elemental information and data relating to the clinical trials on Bladder Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bladder Cancer.

1. Bladder Cancer Global Clinical Trials Review, H1, 2014
Bladder Cancer Global Clinical Trials Review, H1, 2014
Summary
GlobalData's clinical trial report, Bladder Cancer Global Clinical Trials Review, H1, 2014" provides data on the Bladder Cancer clinical trial scenario. This report
provides elemental information and data relating to the clinical trials on Bladder Cancer. It includes an overview of the trial numbers and their recruitment status
as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of
the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bladder Cancer. This report is built using data and
information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five
national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 5
introduction 6
bladder Cancer 6
report Guidance 6
clinical Trials By Region 7
clinical Trials And Average Enrollment By Country 8
top Five Countries Contributing To Clinical Trials In Asia-pacific 10
top Five Countries Contributing To Clinical Trials In Europe 11
top Countries Contributing To Clinical Trials In North America 12
top Countries Contributing To Clinical Trials In Middle East And Africa 13
top Countries Contributing To Clinical Trials In Central And South America 14
clinical Trials By G7 Countries: Proportion Of Bladder Cancer To Oncology Clinical Trials 15
clinical Trials By Phase In G7 Countries 16
clinical Trials In G7 Countries By Trial Status 17
clinical Trials By E7 Countries: Proportion Of Bladder Cancer To Oncology Clinical Trials 18
clinical Trials By Phase In E7 Countries 19
clinical Trials In E7 Countries By Trial Status 20
clinical Trials By Phase 21
in Progress Trials By Phase 22
clinical Trials By Trial Status 23
clinical Trials By End Point Status 24
unaccomplished Trials Of Bladder Cancer 25
subjects Recruited Over A Period Of Time 32
clinical Trials By Sponsor Type 33
prominent Sponsors 34
top Companies Participating In Bladder Cancer Therapeutics Clinical Trials 35
prominent Drugs 37
latest Clinical Trials News On Bladder Cancer 38
jan 13, 2014: Tengion Announces Continued Clinical Progress In Its Neo-urinary Conduit Program 38
dec 30, 2013: Heat Biologics Announces Its Phase 1/2 Study Of Hs-410 In Bladder Cancer Is Open For Enrollment 38
nov 25, 2013: Heat Biologics Successfully Completes Manufacturing Of Hs-410 To Start Phase 1/2 Bladder Cancer Trial 39
jul 16, 2013: Oncogenex Announces Completion Of Patient Enrollment In The Borealis-1 Trial Of Ogx-427 In Metastatic Bladder Cancer 39
apr 30, 2013: Oncogenex Pharma Initiates Phase Ii Bladder Cancer Trial Of Ogx-427 In Combination With Docetaxel 40
clinical Trial Profiles 41
clinical Trial Overview Of Top Companies 41
Bladder Cancer Global Clinical Trials Review, H1, 2014

2. glaxosmithkline Plc 41
clinical Trial Overview Of Glaxosmithkline Plc 41
eli Lilly And Company 43
clinical Trial Overview Of Eli Lilly And Company 43
pfizer Inc. 44
clinical Trial Overview Of Pfizer Inc. 44
spectrum Pharmaceuticals, Inc. 45
clinical Trial Overview Of Spectrum Pharmaceuticals, Inc. 45
sanofi 46
clinical Trial Overview Of Sanofi 46
merck & Co., Inc. 47
clinical Trial Overview Of Merck & Co., Inc. 47
bayer Ag 48
clinical Trial Overview Of Bayer Ag 48
f. Hoffmann-la Roche Ltd. 49
clinical Trial Overview Of F. Hoffmann-la Roche Ltd. 49
endo Health Solutions Inc. 50
clinical Trial Overview Of Endo Health Solutions Inc. 50
bristol-myers Squibb Company 51
clinical Trial Overview Of Bristol-myers Squibb Company 51
clinical Trial Overview Of Top Institutes / Government 52
national Cancer Institute 52
clinical Trial Overview Of National Cancer Institute 52
memorial Sloan Kettering Cancer Center 60
clinical Trial Overview Of Memorial Sloan Kettering Cancer Center 60
european Organization For Research And Treatment Of Cancer 63
clinical Trial Overview Of European Organization For Research And Treatment Of Cancer 63
the University Of Texas M. D. Anderson Cancer Center 65
clinical Trial Overview Of The University Of Texas M. D. Anderson Cancer Center 65
national Bladder Cancer Collaborative Group 67
clinical Trial Overview Of National Bladder Cancer Collaborative Group 67
southwest Oncology Group 69
clinical Trial Overview Of Southwest Oncology Group 69
medical Research Council Clinical Trials Unit 70
clinical Trial Overview Of Medical Research Council Clinical Trials Unit 70
university Of Michigan 71
clinical Trial Overview Of University Of Michigan 71
eastern Cooperative Oncology Group 72
clinical Trial Overview Of Eastern Cooperative Oncology Group 72
medical Research Council 73
clinical Trial Overview Of Medical Research Council 73
five Key Clinical Profiles 74
appendix 134
abbreviations 134
definitions 134
research Methodology 135
secondary Research 135
about Globaldata 136
contact Us 136
disclaimer 136
source 137
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Bladder Cancer Global Clinical Trials Review, H1, 2014

3. Bladder Cancer Global Clinical Trials Review, H1, 2014